1. Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

   • Haiyan Cao
   • Xiaosheng Rao
   • Dong Li

   Review Article 01 November 2022 Pages: 325 - 335

   

2. Pure-protein load for children with type 1 diabetes: is any additional insulin needed? A randomized controlled study

   • Katarzyna Dżygało
   • Kamila Indulska
   • Agnieszka Szypowska

   Original Article 06 December 2022 Pages: 337 - 343

   

3. Prevalence of gestational diabetes mellitus in women with a family history of type 2 diabetes in first- and second-degree relatives

   • Cécile Monod
   • Grammata Kotzaeridi
   • Christian S. Göbl

   Original Article Open access 12 December 2022 Pages: 345 - 351

   

4. Intakes of omega-3 fatty acids and risks of all-cause and cause-specific mortality in people with diabetes: a cohort study based on NHANES 1999–2014

   • Jing Xie
   • Zhenwei Wang
   • Yun Liu

   Original Article 17 December 2022 Pages: 353 - 362

   

5. Quantification of risk factors for diabetic retinopathy progression

   • Dariusz Tarasewicz
   • Carol Conell
   • Ronald B. Melles

   Original Article 17 December 2022 Pages: 363 - 369

   

6. Heated tobacco product use and abnormal glucose metabolism: a working population-based study

   • Huan Hu
   • Toshiaki Miyamoto
   • Tetsuya Mizoue

   Original Article 17 December 2022 Pages: 371 - 378

7. Regional divergence and time trends in the prevalence of gestational diabetes mellitus: a national Danish cohort study

   • Cathrine M. Scheuer
   • Maria H. Andersen
   • Tine D. Clausen

   Original Article Open access 20 December 2022 Pages: 379 - 386

   

8. The m⁶A reader YTHDC2 promotes SIRT3 expression by reducing the stabilization of KDM5B to improve mitochondrial metabolic reprogramming in diabetic peripheral neuropathy

   • Yang Jiao
   • Shu Wang
   • Yong-Hao Yu

   Original Article 27 December 2022 Pages: 387 - 399

   

9. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment

   • Zhichao He
   • Kakei Lam
   • Junyan Wu

   Original Article 28 December 2022 Pages: 401 - 411

   

10. Risk prediction of nephropathy by integrating clinical and genetic information among adult patients with type 2 diabetes

    • Li-Na Liao
    • Tsai-Chung Li
    • Cheng-Chieh Lin

    Original Article 28 December 2022 Pages: 413 - 424

    

11. Gender gaps in type 1 diabetes care

    • Jessica C. G. Bak
    • Erik H. Serné
    • Carianne L. Verheugt

    Original Article 02 January 2023 Pages: 425 - 434

    

12. Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: an updated meta-analysis

    • Yunke Ma
    • Chu Lin
    • Linong Ji

    Original Article 07 January 2023 Pages: 435 - 445

    

13. Validation of glycated albumin reference interval in healthy Caucasian pregnant women

    • Luisa Agnello
    • Rosaria Vincenza Giglio
    • Marcello Ciaccio

    Short Communication 25 October 2022 Pages: 447 - 448

14. Incomplete phenotypic presentation in a girl with rare Rabson–Mendenhall syndrome

    • Joanna Chrzanowska
    • Jagoda Skarul
    • Agnieszka Zmyslowska

    Case Report Open access 04 November 2022 Pages: 449 - 453

    

15. Can a mental health treatment reduce admissions for diabetic ketoacidosis?

    • Christopher J. Garrett
    • Calum D. Moulton
    • Khalida Ismail

    Letter to the Editor 16 November 2022 Pages: 455 - 457

16. Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

    • Antonella Marucci
    • Rosa Di Paola
    • Vincenzo Trischitta

    Correction 27 January 2023 Pages: 459 - 459